Learning doesn't stop with your nursing degree!

We believe that nurses who are lifelong learners deliver better patient care. That’s why PCNA is committed to providing you with the continuing education resources you need to provide evidence-based care in the fast-changing world of cardiovascular nursing.

Although we would love to meet all of you face-to-face at our Annual Symposium, or at our many local programs, we know that web-based learning is an important (and convenient!) option too.

See a program that is free or discounted to members? Join PCNA to take advantage of this benefit!

Please note: Learners claiming credit for a live CE program (either face-to-face or webinar) cannot claim credit for the on-demand archived version of the same program.

continuing education laptop

Find the CE Courses You Need

View all our on-demand continuing education below, or search courses by course topic, number of continuing education or pharmacology credits, and cost. New continuing education courses are being added all the time, so check back often!

On Demand Library


2021 Cardiovascular Nursing Symposium: General Sessions

9.25 CE contact hours,
1.5 CE pharmacology hours

2021 Health Equity Summit Day 1

0 CE contact hours,
0 CE pharmacology hours

2021 Health Equity Summit Day 2

0 CE contact hours,
0 CE pharmacology hours

2021 Pharmacology Sessions

5.0 CE contact hours,
4.75 CE pharmacology hours

Advancing Patient-Centered Care Through Shared Decision Making

1.0 CE contact hours

Aortic Stenosis: Awareness and Identification

0.5 CE contact hours,
0 CE pharmacology hours

Aortic Stenosis: Healthy vs. Unhealthy Aortic Valve

0.25 CE contact hours,
0 CE pharmacology hours

Aortic Stenosis: Team-Based Care and Shared Decision Making

0.4 CE contact hours,
0 CE pharmacology hours

Aortic Stenosis: Treatments

0.5 CE contact hours,
0 CE pharmacology hours

Cardiac Diagnostics: Using Data to Assess Risk, Diagnose and Treat CVD

1.0 CE contact hours

Cardio-Oncology: Preventing and Treating Cardiovascular Complications Associated with Cancer Treatments

0.75 CE contact hours,
0.5 CE pharmacology hours

Cardiovascular Nursing Certificate

0 CE contact hours,
0 CE pharmacology hours

Caring for Ourselves So We Can Care for Others

1.0 CE contact hours

Case Studies in Cardiovascular Risk Reduction with Non-statin Therapies: Rapid Fire Roundtable

1.0 CE contact hours,
0.7 CE pharmacology hours

Connecting Diabetes and Heart Disease

1.0 CE contact hours,
0.3 CE pharmacology hours

Disability Awareness and Etiquette in Health Promotion

1.0 CE contact hours

Effective Diagnosis and Treatment of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

1.0 CE contact hours

Exercise and Lifestyle Interventions: What’s their Role in Cardiovascular Disease (CVD) Prevention and Treatment?

1.0 CE contact hours

Genetic Counseling and Inherited CVD: A Family Affair

0.75 CE contact hours

Global Prespectives in Cardiovascular Nursing

0 CE contact hours,
0 CE pharmacology hours

GLP-1 Receptor Agonists and Cardiovascular Outcomes

0.50 CE contact hours,
0.50 CE pharmacology hours

Heart Failure and Social Determinants of Health: Across Race and Gender

0.65 CE contact hours,
0.00 CE pharmacology hours

Heart Failure and Social Determinants of Health: The Foundation

0.75 CE contact hours,
0.00 CE pharmacology hours

Heart Failure Course: Sex Differences in Prevention and Management

0.75 CE contact hours

Homozygous Familial Hypercholesterolemia (HoFH): Patient Perspectives

0 CE contact hours,
0 CE pharmacology hours

Improving Adherence to Cholesterol-lowering Therapies

0 CE contact hours,
0 CE pharmacology hours

Inflammation and Cardiovascular Disease: Understanding the Relationship

0.75 CE contact hours

Influenza: Cardiovascular Risks and Considerations During the COVID-19 Pandemic

0 CE contact hours,
0 CE pharmacology hours

Interpreting and Translating Research into Practice

0 CE contact hours,
0 CE pharmacology hours

Is it Cardiac or Pulmonary? Patient Assessment and Diagnostic Evaluation of Dyspnea

1.0 CE contact hours

Ischemic Heart Disease and Microvascular Angina: Current Trends in Diagnosis and Management

0.75 CE contact hours

Lipid Management in 2019: Putting Evidence-Based Guidelines into Practice

1.0 CE contact hours,
0.7 CE pharmacology hours

Lipoprotein(a) and ASCVD Risk

0 CE contact hours,
0 CE pharmacology hours

Making the Link Between Diabetes and Cardiovascular Disease

1.0 CE contact hours,
0.8 CE pharmacology hours

Navigating Resources to Assist Patients in Managing CVD

0.25 CE contact hours

New and Emerging Treatments for Heart Failure: HFrEF and HFpEF

0.85 CE contact hours,
0.85 CE pharmacology hours

New Hypertension Guidelines: Matching Risks and Treatments

0.75 CE contact hours

Non-Statin Therapies for Lipid Management

0.75 CE contact hours,
0.75 CE pharmacology hours

Nurses Role in Managing Patients with Heart Failure – Hospital to Home

1.0 CE contact hours

Online Pharmacology Course 2019

5.0 CE contact hours,
3.7 CE pharmacology hours

Optimal Nutrition for Cardiovascular Risk Reduction

0.83 CE contact hours

Optimizing the Care of Heart Failure Patients: Best Practices in Telemedicine

1.0 CE contact hours

Overcoming Provider and Patient Inertia

0 CE contact hours,
0 CE pharmacology hours

Pediatric Prevention Guidelines

0.75 CE contact hours

Peripheral Artery Disease (PAD) Awareness: Reducing Health Disparities

1.0 CE contact hours,
0.25 CE pharmacology hours

Prevention and Treatment of Venous Thromboembolism (VTE) from Hospital to Home

1.0 CE contact hours,
0.25 CE pharmacology hours

Regenerative Medicine, Stem Cells and Heart Disease: Current Applications and Future Direction

0.75 CE contact hours

Secondary Prevention in Acute Coronary Syndrome: What Nurses Need to Know

1.0 CE contact hours

SGLT2 Inhibitors and Cardiovascular Outcomes

1.0 CE contact hours,
1.0 CE pharmacology hours

Shared Decision-Making and Quality of Life in Patients with Heart Failure

1.0 CE contact hours

Smoking Cessation: Counseling Strategies and Pharmacologic Treatments

1.0 CE contact hours

Socioeconomic Impact of Heart Failure Hospitalization and Readmission

1.0 CE contact hours

Symptomatic Hypertrophic Cardiomyopathy: Case-Based Management

0.00 CE contact hours,
0.00 CE pharmacology hours

Symptoms and Skeletal Muscle in Persons with Heart Failure with Preserved Ejection Fraction

0.25 CE contact hours

The 2019 Guideline for Primary Prevention of Cardiovascular Disease

1.0 CE contact hours

The QT Interval: Too Hot, Too Cold, Just Right

0.75 CE contact hours,
0.5 CE pharmacology hours

The Role of Non-Statin Therapies in Optimal Cholesterol Management

0 CE contact hours,
0 CE pharmacology hours

Transitioning from Acute to Chronic Lipid Management

0 CE contact hours,
0 CE pharmacology hours

Treating High-Risk Patients with Non-Statin Therapy for LDL-C Lowering: Optimizing Clinical Outcomes

1.0 CE contact hours,
0.8 CE pharmacology hours

Women and CVD: Creating Awareness and Making Prevention a Priority

1.0 CE contact hours